Search results for ' Tocilizumab'

Remdesivir black-market thrives as Covid cases rise

Remdesivir black-market thrives as Covid cases rise

Rediff.com6 May 2021

Artificial shortages and brazen hawking of the drug on the streets at 15 times the normal price rule the day as the official machinery tries desperately to stamp out the parallel market, reports Sohini Das

Covid-19: Delhi short on oxygen, beds, says Kejriwal

Covid-19: Delhi short on oxygen, beds, says Kejriwal

Rediff.com17 Apr 2021

The number of COVID-19 cases are rising rapidly with 24,000 fresh cases reported in the last 24 hours, he said in an online media briefing.

Health ministry okays HCQ for early course of COVID-19

Health ministry okays HCQ for early course of COVID-19

Rediff.com13 Jun 2020

The health ministry on Saturday recommended the use of antiviral drug remdesivir in moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.

Test for TB if cough persists: Govt's revised Covid guidelines

Test for TB if cough persists: Govt's revised Covid guidelines

Rediff.com18 Jan 2022

Anti-inflammatory or immunomodulatory therapy, such as steroids, can have the risk of secondary infection like invasive mucormycosis, when used too early, at higher dose or for longer than required, they highlighted.

8 vaccines, 4 treatments in India's COVID-19 arsenal

8 vaccines, 4 treatments in India's COVID-19 arsenal

Rediff.com28 Dec 2021

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.

GST cut on Covid drugs, equipment, retained for vaccines

GST cut on Covid drugs, equipment, retained for vaccines

Rediff.com12 Jun 2021

Pulse oximeters, hand sanitisers, temperature check equipment and ambulances too will attract lower 5 per cent tax.

Covid drug sales shine even as market slows

Covid drug sales shine even as market slows

Rediff.com18 Aug 2020

Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation.

'No preparedness planning, no accountability, no action plan'

'No preparedness planning, no accountability, no action plan'

Rediff.com8 May 2021

'This government did not have any plan for safety stocks of essential medicines.'

CoWIN portal in Hindi, other languages from next week: Govt

CoWIN portal in Hindi, other languages from next week: Govt

Rediff.com17 May 2021

The CoWIN portal will be made available in Hindi and 14 regional languages by next week, while 17 more laboratories will be added to the INSACOG network to monitor the variants of COVID-19, the health ministry said on Monday.

India's COVID-19 fatality rate slides to 1.76%: Govt

India's COVID-19 fatality rate slides to 1.76%: Govt

Rediff.com2 Sep 2020

As many as 1,578 dedicated COVID hospitals are providing quality medical care.

Pharma industry posts 51.5% growth in April sales

Pharma industry posts 51.5% growth in April sales

Rediff.com8 May 2021

When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent.

Cipla ready to partner in Covid vaccine distribution

Cipla ready to partner in Covid vaccine distribution

Rediff.com17 May 2021

However, Cipla was very clear it does not want to get into vaccine manufacturing.

3rd wave: Govt creating 30-day stock of key Covid medicines

3rd wave: Govt creating 30-day stock of key Covid medicines

Rediff.com26 Jul 2021

'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What's better is that this time, the government is paying us in advance,' said a senior executive of a Mumbai-based pharma player which makes Remdesivir. Sohini Das reports.

Remdesivir not magic bullet, does not reduce mortality: Experts

Remdesivir not magic bullet, does not reduce mortality: Experts

Rediff.com19 Apr 2021

'It was of no use if given early in mild and asymptomatic patients and also if administered too late'

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Rediff.com6 Oct 2020

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.

Centre's allocation of black fungus drug irrational: HC

Centre's allocation of black fungus drug irrational: HC

Rediff.com10 Jun 2021

The Bombay high court on Thursday said the Union government's allocation of Amphotericin-B, a key drug used in the treatment of mucormycosis or black fungus, appeared to be irrational, and the supply to Maharashtra was not adequate considering the number of cases in the state.

India allows use of steroid to treat COVID-19 patients

India allows use of steroid to treat COVID-19 patients

Rediff.com27 Jun 2020

According to the revised 'Clinical Management Protocols for COVID-19', dexamethasone which is already used in treating lung infections besides in a wide range of conditions for its anti-inflammatory and immunosuppressant effects can be used as an alternative to methylprednisolone which already existed in the treatment guidelines.

Black fungus: 8 Covid survivors die in Maha, Guj reports 50 cases

Black fungus: 8 Covid survivors die in Maha, Guj reports 50 cases

Rediff.com8 May 2021

The fungus, also called `black fungus', is present in the environment, but those with suppressed immunity or co-morbidities are more vulnerable to its infection, he said.

Will petrol, diesel come under the ambit of GST?

Will petrol, diesel come under the ambit of GST?

Rediff.com14 Sep 2021

The GST Council might on Friday consider taxing petrol, diesel and other petroleum products under the single national GST regime, a move that may require huge compromises by both central and state governments on the revenues they collect from taxing these products. The Council, which comprises central and state finance ministers, in its meeting scheduled in Lucknow on Friday, is also likely to consider extending the time for duty relief on COVID-19 essentials, according to sources in the know of the development. GST is being thought to be a solution for the problem of near-record high petrol and diesel rates in the country, as it would end the cascading effect of tax on tax (state VAT being levied not just on the cost of production but also on the excise duty charged by the Centre on such output).

India sees highest spike of 2,003 COVID-19 deaths

India sees highest spike of 2,003 COVID-19 deaths

Rediff.com18 Jun 2020

Prime Minister Narendra Modi on Wednesday asked states to make full use of the expanded COVID-19 testing capacity and saving lives a top priority as India recorded the highest ever spike of 2,003 coronavirus deaths after Maharashtra and Delhi added earlier fatalities not attributed to the disease.

India was there for us, we will be there for them: Biden

India was there for us, we will be there for them: Biden

Rediff.com27 Apr 2021

"The president pledged America's steadfast ongoing support for the people of India, who have been impacted by the recent surge in the COVID-19 cases," White House Press Secretary Jen Psaki told reporters at her daily news conference.

Swiggy, Zomato to pay 5% GST to govt; food won't cost more

Swiggy, Zomato to pay 5% GST to govt; food won't cost more

Rediff.com17 Sep 2021

The all-powerful GST Council on Friday decided to charge food delivery platforms such as Swiggy and Zomato a tax even as it extended concessional tax rates on certain COVID-19 drugs by three months till December 31. The Council, which comprises the Union finance minister and her state counterparts, decided to continue keeping petrol and diesel out of the GST purview as subsuming the current excise duty and VAT into one national rate would impact revenues. Briefing reporters on the decisions taken by the Council at a meeting here, Union Finance Minister Nirmala Sitharaman said GST has been exempted on muscular atrophy drugs like Zolgensma and Viltepso, which cost crores of rupees.

Conmen cash in on Covid desperation amid 2nd wave

Conmen cash in on Covid desperation amid 2nd wave

Rediff.com18 May 2021

At a time when the country's medical infrastructure has become incapable of handling the pressure of Covid's deadly second wave, a parallel wave of conmen, black marketers and counterfeiters can be witnessed across the country. Geetanjali Krishna reports.

How we can DEFEAT COVID-19

How we can DEFEAT COVID-19

Rediff.com17 Mar 2021

'If people are not cooperating and do not follow policies laid down by the government or follow scientific infection control management, then all will be lost.'

India overtakes US to record highest number of COVID-19 recoveries

India overtakes US to record highest number of COVID-19 recoveries

Rediff.com19 Sep 2020

The country has reported the highest number of recoveries with 42,08,431 COVID-19 patients having recovered from the disease so far, pushing the national recovery rate to nearly 80 per cent, while the case fatality rate has further dropped to 1.61 per cent, the ministry said.

UP cabinet minister Kamal Rani succumbs to COVID-19

UP cabinet minister Kamal Rani succumbs to COVID-19

Rediff.com2 Aug 2020

The Technical Education minister, who tested positive for COVID-19 on July 18 and is the first minister in the state to succumb to the disease, breathed her last at the Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPIMS).

Modi govt firm to help Bengal fight Covid: Vardhan to Mamata

Modi govt firm to help Bengal fight Covid: Vardhan to Mamata

Rediff.com8 May 2021

With West Bengal Chief Minister Mamata Banerjee seeking a uniform vaccination policy for the country, Union Health Minister Harsh Vardhan on Friday assured her that the Modi government was firm in its resolve to help the state fight the COVID-19 pandemic, but also flagged more than 40 per cent positivity rate in some districts of the state.

COVID-19: Lessons to be learnt from Delhi, Mumbai

COVID-19: Lessons to be learnt from Delhi, Mumbai

Rediff.com27 Jul 2020

The two cities finally got their act together by ramping up the testing capacity and implementing stricter quarantine norms.

'Only 4 drugs reduce COVID-19 mortality. Everything else is stupidity'

'Only 4 drugs reduce COVID-19 mortality. Everything else is stupidity'

Rediff.com18 Jun 2021

'Unfortunately, during this pandemic, everybody started saying that well, these are desperate times and desperate times need desperate solutions.' 'Purely out of fear, anxiety, panic, this knowledge that people started acquiring from WhatsApp University and social media, it pushed science completely to the backseat.'

Get your house in order: HC rebukes Delhi govt over blackmarketing of oxygen cylinders and medicines

Get your house in order: HC rebukes Delhi govt over blackmarketing of oxygen cylinders and medicines

Rediff.com27 Apr 2021

During an over three-hour hearing on the matter relating to oxygen crisis and shortage of medicines to treat COVID-19 patients in the national capital, the court observed that the "problem lies with the Delhi government" and directed nodal officer Udit Prakash to ensure supply of oxygen by cylinders to hospitals and nursing homes "without fail".

As India records 2.34 lakh Covid cases, PM urges: Test, track, treat

As India records 2.34 lakh Covid cases, PM urges: Test, track, treat

Rediff.com17 Apr 2021

Top officers across various ministries participate in the meeting that started at 8 pm on Saturday. The meeting is currently underway. The country is currently witnessing a second and more severe wave of the pandemic.

How Indian pharma bounced back from lockdown lows

How Indian pharma bounced back from lockdown lows

Rediff.com7 Dec 2020

From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies - Indian drug makers have shown that medicine sales is certainly a sunshine sector.

No community transmission in India yet, says govt

No community transmission in India yet, says govt

Rediff.com9 Jul 2020

India's COVID-19 cases and deaths per million population are amongst the lowest in the world, the govt says.

COVID-19: 'Good behaviour will reduce deaths'

COVID-19: 'Good behaviour will reduce deaths'

Rediff.com27 Aug 2020

'We cannot be naughty and expect the government to do good!' 'We have to behave ourselves and then we can expect the government to support us.' 'If we are able to protect ourselves well, then we should not be having deaths.' 'Unfortunately, people have gotten into this super scary event participation (mode) -- birthday parties, large gatherings.' 'Among the people who have attended those, 80 to 90 per cent of them have come down with COVID-19.'

Maharashtra, TN account for 50% of active COVID-19 cases: Govt

Maharashtra, TN account for 50% of active COVID-19 cases: Govt

Rediff.com15 Jul 2020

The health ministry said that 86 per cent of the total active cases were recorded in 10 states of the country.

What I learnt from fighting COVID-19

What I learnt from fighting COVID-19

Rediff.com24 Aug 2020

'The genetic thing is not in your control. The virulence is not known.' 'The only thing is if you can avoid it.' 'Once you get COVID-19, none of it is in your control.'

'We are very close to the peak in Mumbai'

'We are very close to the peak in Mumbai'

Rediff.com25 May 2020

'There is just one silver lining: The fatality rate has gone down.'

COVID-19: Why are so many young people dying?

COVID-19: Why are so many young people dying?

Rediff.com8 Jul 2020

'We started analysing young patients and realised that they had causes like undetected diabetes, which suddenly flares up during COVID-19.' 'Secondly, hypothyroidism was one of the factors.' 'And obesity.'

'Modi govt failed to understand or to tackle COVID'

'Modi govt failed to understand or to tackle COVID'

Rediff.com1 May 2021

As India logged a world record of over four lakh coronavirus infections on Saturday, Congress leader Rahul Gandhi said the entire world is shaken by what is happening here and accused Prime Minister Narendra Modi of "dropping the ball and throwing it to states" after prematurely taking credit for having "won against COVID-19" when the second wave was already underway. "Rely on yourself is the motto. No one will come to help you. Definitely, not the prime minister," Gandhi said, while alleging that the COVID-19 situation has gone completely out of control for the Modi government, and wondered whether it was their way of making the states and the citizens truly 'Aatmanirbhar'.

'We are learning from every patient who dies'

'We are learning from every patient who dies'

Rediff.com19 Aug 2020

'We are learning from every patient who is admitted, treated and discharged.'